Advertisement

Topics

Saitama Daiichi Pharmaceutical Co., Ltd. Company Profile

18:37 EDT 25th September 2018 | BioPortfolio

Since the founding of our company in 1963, we have steadily advanced in the areas of research and development and production, in the sincere pursuit of people's health. In this quest, we have become an industry leader in the research, development and production of ointments and liquid preparations, working diligently to meet ever-growing expectations. Some of our success stories include the ethical drugs, Miltax and Actosin Ointment as well as the molded cataplasms, Patecs series and Karoyan series.In recent years, there has been a growing interest in Drug Delivery System (DDS), among the domestic and foreign medical industries. We are actively at work in this field of research and development, especially Ttansdermal Therapeutic Systems (TTS, that provide lasting pharmacological effect with less side effects), with steady and specific progress toward practical application. Applying these technologies, we are engaged in commissioned research and development with other companies, both foreign and domestic. In order to serve the aging society of the future, we continue to further strengthen our research and development of drugs to treat and prevent diseases. In addition, our experience in production technology will allow us to make further advances in commissioned production.
Look to Saitama Daiichi Pharmaceutical Co., Ltd. for future progress.

Location

8-1, Minamisakae-cho
Kasukabe
Saitama
344-0057
Japan

Contact

Phone: 81-48-752-7151


News Articles [303 Associated News Articles listed on BioPortfolio]

Daiichi Sankyo to restructure vaccines subsidiary

Daiichi Sankyo is set to restructure its wholly-owned Kitasato Daiichi Sankyo Vaccine subsidiary into a specialised manufacturing division to enhance...Read More... The post Daiichi Sankyo to restruct...

Deals this week: Daiichi Sankyo, MannKind, Dova Pharmaceuticals

Daiichi Sankyo has transferred 41 of its long-listed products to Alfresa Pharma. The transaction also includes products manufactured by Daiichi...Read More... The post Deals this week: Daiichi Sankyo,...

Daiichi Sankyo to develop new inflammatory disease drugs

Daiichi Sankyo has formed a new consortium focused on research and discovery of medicines over a period of five years...Read More... The post Daiichi Sankyo to develop new inflammatory disease drugs a...

BRIEF—Hitachi and Daiichi Sankyo reach manufacturing accord

Chūō, Tokyo-based pharmaceutical firm Daiichi Sankyo has awarded Hitachi Chemical a contract to manufacture…

Daiichi Sankyo transfers 41 products to Alfresa Pharma

Daiichi Sankyo has announced plans to split and transfer its inventories to Alfresa Pharma, along with Japanese manufacturing and sales...Read More... The post Daiichi Sankyo transfers 41 products to ...

Deals this week: Twist Bioscience, Kangmei Pharmaceutical, Daiichi Sankyo

Twist Bioscience has completed a private placement of shares to raise $50m. The company plans to use part of the...Read More... The post Deals this week: Twist Bioscience, Kangmei Pharmaceutical, Daii...

EHA 2018: pivotal Phase III data for Daiichi Sankyo’s quizartinib

Daiichi Sankyo’s pivotal data presentation at this year’s European Hematology Association (EHA) annual meeting showed that its FLT3 inhibitor quizartinib...Read More... The post EHA 2018: pivotal ...

Glycotope GmbH: Daiichi Sankyo Enters Worldwide Licensing Agreement with Glycotope for Gatipotuzumab Antibody Drug Conjugate

TOKYO, BERLIN, BASKING RIDGE, NJ / ACCESSWIRE / July 30, 2018 / Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and Glycotope GmbH (hereafter, Glycotope) have entered into an exclusive ...

Drugs and Medications [285 Associated Drugs and Medications listed on BioPortfolio]

Benicar [Daiichi Sankyo, Inc]

These highlights do not include all the information needed to use Benicar safely and effectively. See full prescribing information for Benicar. Benicar (olmesartan medoxomil) tablets Initial U.S. Appr...

Evoxac capsules(cevimeline hydrochloride) [Daiichi Sankyo Pharma Development]

EVOXAC Capsules(cevimeline hydrochloride)

Emetrol cherry [WellSpring Pharmaceutical Corporation]

Emetrol

Cetirizine hydrochloride [Pharmaceutical Associates, Inc.]

Cetirizine Hydrochloride Syrup

Giltuss total release [Gil Pharmaceutical Corp]

Drug Facts

PubMed Articles [499 Associated PubMed Articles listed on BioPortfolio]

Long-term outcomes of patients evacuated from hospitals near the Fukushima Daiichi nuclear power plant after the Great East Japan Earthquake.

After the accident of the Fukushima Daiichi nuclear power plant due to the Great East Japan Earthquake in March 2011, the Japanese government issued a mandatory evacuation order for people living with...

Radiocesium contamination in house dust within evacuation areas close to the Fukushima Daiichi nuclear power plant.

Outdoor decontamination efforts have been ongoing since the Fukushima Daiichi nuclear power plant (FDNPP) accident; however, little is known about indoor contamination. Therefore, house dust was sampl...

Atmospheric activity concentration of Sr and Cs after the Fukushima Daiichi Nuclear Accident.

On 11 March 2011, the Fukushima Daiichi Nuclear Power Plant (FDNPP) accident occurred and a large amount of radionuclides were discharged into the atmosphere. We have operated continuous aerosol sampl...

Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates.

Within (European) healthcare systems, the predominant goal for pharmaceutical expenditure is cost containment. This is due to a general belief among healthcare policy makers that pharmaceutical expend...

Applications of various analytical techniques in quality control of pharmaceutical excipients.

Although excipients are pharmacologically inert substances, still they are integral and significant ingredients of a pharmaceutical formulation. Their amount and concentration level along with the act...

Clinical Trials [325 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Olmesartan Medoxomil Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Olmesartan Medoxomil Tablets 40 mg and Benicar® 40 mg Tablets of Daiichi Sankyo Inc., USA. Dosing periods of studies were ...

Comparative Study of Loxoprofen Sodium Transdermal Patch and Loxonin® Tablets for the Treatment of Acute Trauma

This study evaluates the non-inferiority of the new transdermal patch dosage form containing loxoprofen sodium (100 mg - Daiichi-Sankyo) in comparison with oral Loxonin® (60 mg tablet - D...

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

Companies [1057 Associated Companies listed on BioPortfolio]

Saitama Daiichi Pharmaceutical Co., Ltd.

Since the founding of our company in 1963, we have steadily advanced in the areas of research and development and production, in the sincere pursuit of people's health. In this quest, we have become a...

DAIICHI SANKYO EUROPE GmbH and SHARE

DAIICHI SANKYO is a global pharmaceutical company that focuses on researching and marketing innovative medications. The company was created in 2005 through the merger of two traditional Japanese e...

Daiichi Fine Chemical Co., Ltd

Daiichi Fine Chemical Co., Ltd. united the fine chemical business of Daiichi Pharmaceutical Group in October 2001.In the economic and social environment in which changes are expected to accelerate in ...

Daiichi Sankyo

The Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients in both mature and emerging markets. ...

Daiichi Sankyo Company, Limited

Daiichi Sankyo Company, Limited, established in 2005 after the joint share transfer of two leading century-old Japanese pharmaceutical companies, is continuously generating innovative drugs that e...

More Information about "Saitama Daiichi Pharmaceutical Co., Ltd." on BioPortfolio

We have published hundreds of Saitama Daiichi Pharmaceutical Co., Ltd. news stories on BioPortfolio along with dozens of Saitama Daiichi Pharmaceutical Co., Ltd. Clinical Trials and PubMed Articles about Saitama Daiichi Pharmaceutical Co., Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Saitama Daiichi Pharmaceutical Co., Ltd. Companies in our database. You can also find out about relevant Saitama Daiichi Pharmaceutical Co., Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record